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Starting from a mixture of enantiomers in solution, crystallization can generate different types of
crystals. In order to determine which type of crystal is obtained in the case of acetyl leucine, an active
pharmaceutical ingredient (API), analytical methods have been used to partially elucidate the binary
and ternary phase diagrams of the system composed of the two enantiomers and water.
The melting temperature phase diagram of this compound has been obtained by using differential
scanning calorimetry (DSC) analyzes. The results show that it is characteristic of a conglomerate. This
mode of crystallization has also been confirmed by X-ray powder diffraction analysis.
Solubility measurements of enantiomerical mixtures in water enabled the determination of the
ternary diagram of solubility. The empiric Meyerhoffer double solubility rule has been modified, due to
the characterization of interactions between enantiomers.
1. Introduction
Life is essentially constructed using L-amino acids as building
blocks, which are enantiomers, that is to say chiral compounds
that are non-superimposable mirror images at each other. In
many cases, only one enantiomer provides the desired physiolo-
gical effect whereas the other enantiomer has no effect. Thus,
there is an important interest in the pharmaceutical, food and
agrochemical industries to produce pure enantiomers or to
separate them from a racemic mixture. An economical way to
obtain pure enantiomer is the separation by crystallization as
Pasteur did with sodium ammonium tartrate enantiomers [1]. As
opposite enantiomers can crystallize in the same crystal or
separately, the feasibility of a selective crystallization is then
strongly dependent on the mode of crystallization of the com-
pound. The design and the optimization of a crystallization
process thus rely on the knowledge of the type of the enantio-
merical crystallization [2].
Three different types of crystallization, corresponding to the three
different kinds of racemates [3,4], are usually identified (see Fig. 1) :
 The conglomerate (or racemic conglomerate) consists of a
physical mixture of pure crystals of one enantiomer and its
counterpart. In the crystal structure, molecules have a greater
affinity for the same enantiomer than for the counterpart and
the two enantiomers crystallize separately. Only 5–10% of the
racemic mixtures belong to the conglomerate-forming
group [5].
 The true racemate (or racemic compound) is formed by a
single crystalline phase in which the two enantiomers are
ordered in a 1:1 ratio. In this case, molecules have a greater
affinity for the counterpart than for the same enantiomer. The
racemic compound behaves as a pure compound and has its
own physical properties.
 The racemic solid solution (or pseudoracemate) is a crystal
composed of both enantiomers, in equal proportions, but
coexisting in an unordered manner in the crystal lattice,
because there is no significant difference in affinity between
the same and opposite enantiomers.
Each mode has its own physical properties [3]: melting tempera-
ture [6], solubility in a given solvent [7], structure [4] or density
[8,9]. These differences enable the determination of the mode of
crystallization of a compound by building phase diagrams (see
[10] for the propanolol hydrochloride case), which are useful for
the control of the crystallization process.
The molecule studied in this paper is acetyl leucine. Its pharma-
ceutical activity is detailed by Neuzil et al. [11]. This API is found in
the final drug as acetyl-DL-leucine, an equimolar mixture of acetyl-D-
leucine and acetyl-L-leucine. The chemical way of preparation of this
API is well known and studied [12]. Previous works have also been
carried out on enantiomers separation of acetyl-DL-leucine by solvent
extraction [13] or by preferential crystallization method [14]. How-
ever, to our knowledge, no thermodynamic data are available in the
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literature for this compound and for the building of its phase
diagrams. This is usually the case for enantiomerical systems
[2,15]. The goal of this paper is then to determine the type of
crystallization of this compound and to explain the possible separa-
tion of its enantiomers, by determining the binary phase diagram of
melting temperature and the ternary diagram of solubility of this
compound in water.
2. Materials and method
2.1. Materials
Three different forms of acetyl leucine were used in this work:
the two enantiomerical forms, named D and L, and the racemic
form, named acetyl-DL-leucine. All these products were provided
by Pierre Fabre laboratories with a HPLC purity of 99.9%, eval-
uated by HPLC. The solvent used was bidistilled water.
2.2. Methods
2.2.1. Enantiomer mixture preparation
Two different kinds of mixture were used in this study:
 Physical mixtures which are prepared by mixing dry crystals in
different ratios of acetyl-L-leucine and acetyl-D-leucine (ran-
ging from 10% to 90%). Two kinds of physical mixtures were
prepared: either by mixing both enantiomers [16,17], or by
mixing the racemate (acetyl-DL-leucine) with one of the pure
enantiomers.
 Recrystallized samples obtained from under-saturated aqueous
solutions of enantiomers slowly heated in an oven at 50 1C in
order to generate crystallization by solvent evaporation [18].
2.2.2. Thermal characterization
Classical and modulated differential scanning calorimetry
(DSC) profiles were obtained with a TA Instruments Q2000. The
apparatus was calibrated using the melting enthalpy of indium
(28.5 J/g) used as a reference [19].
For DSC analyzes, the samples (4–6 mg) were introduced into a
20 mL aluminum crucible. Sealed crucibles were heated at a
temperature rate of 1 or 5 1C/min, from 0 to 200 1C, under a
stream of nitrogen (50 mL/min). The melting temperature corre-
sponds to the extrapolated onset temperature.
2.2.3. X-ray powder diffraction (XRPD)
X-ray powder diffraction pattern was recorded in transmission
mode on a D8 Advance diffractometer q/q (Bruker AXS) operating
with copper radiation (Ka¼1.54060 A˚) and fitting with the Vantec
detector. The parallel beam geometry (Go¨bel mirror) was used,
with a divergence slit of 0.2 mm. The powder samples were sealed
in 1 mm quartz capillary tube. Data were recorded at 22 1C with a
step size of 0.0071 and a counting time of 2 s/step from 21 to 601.
2.2.4. Solubility measurements
Solubility measurements were carried out in water with
physical mixtures of enantiomers by the analytical shake-flask
method, using constant-temperature jacketed glass cells. A con-
stant temperature of 25 1C (70.1 1C) was maintained with circu-
lating water bath. The way of preparing the saturated solutions
was slightly modified compared to the classical method. Here,
solubility was determined by adding weighed quantities of pow-
der mixture to a known volume of distilled water, until crystals
cannot be dissolved anymore. Small amounts of solid (about
20 mg) were added each time and no addition was performed
before the solution was clear. When the equilibrium was reached,
solutions were stirred for 24 h. The pH of the saturated solutions
was then measured, using a pH meter pHM210 from Radiometer
Analytical with a pHC3001 electrode and the mass of solid added
was calculated in order to get the solubility.
The uncertainty of solubility determination DS is lower
than 5%.
3. Results and discussion
3.1. Binary phase diagram
3.1.1. DSC analysis
In a mixture of enantiomers, some physical properties are
modified according to the composition of enantiomers [3,20]. The
evolution of these properties, reported in a phase diagram, is
characteristic of the type of crystallization of the compound. Fig. 2
shows the evolution of the typical melting phase diagrams, for the
three modes of crystallization [4].
If crystals form a racemic conglomerate (part a) of Fig. 2, there
is only one eutectic point obtained for equimolar composition,Fig. 1. Crystallization modes of racemic mixtures.
Fig. 2. Different types of melting temperature binary diagrams: (a) racemic conglomerate; (b) true racemate and (c) solid solution.
and its melting temperature is always lower than the pure
enantiomer one. The addition of a small amount of one enantio-
mer to the conglomerate increases the melting temperature.
If crystals form a true racemate (Fig. 2b), there are two eutectic
points, symmetrical in relation to the equimolar composition,
with lower melting temperatures than the racemic compound
one. In that case, the addition of a small amount of one
enantiomer to the racemic compound decreases the melting
temperature. However, the pure enantiomer may have a higher
or lower melting temperature than the true racemate.
Finally, in the case of a solid solution, the evolution of the
melting temperature is difficult to predict and there is no eutectic
point. Part (c) of Fig. 2 gives the example of one kind of solid
solution [21] but other solid solution phase diagrams can be
found [22].
DSC thermograms of physical mixtures of enantiomers (acetyl-
L-leucine and acetyl-D-leucine) and of racemate (acetyl-DL-leu-
cine) with one enantiomer are, respectively, reported in
Figs. 3 and 4.
First, in the case of pure enantiomer, only one endothermic
peak corresponding to the melting of the crystals is obtained
whereas when mixtures were analyzed by DSC, two distinct peaks
appear. The thermograms given in Fig. 3 clearly show that the
temperature corresponding to the first peak is constant (158 1C)
for all the mixtures studied. This temperature corresponds to the
melting temperature of the eutectic. The second peak depends on
the enantiomer composition. It defines the liquidus curve in the
liquid–solid diagram. When the composition of the mixture
becomes close to the racemic composition, the second peak is
close to the eutectic one. For example, in the cases of the mixtures
(30% L–70% D) and (60% L–40% D) shown in Fig. 3, the two peaks
overlap each other and it is not possible to separate the
two peaks.
Physical mixtures of pure enantiomers can be representative
of conglomerates, in which each enantiomer crystallizes sepa-
rately, with their own crystal structure. This kind of mixtures
cannot represent true racemate or solid solution, in which both
enantiomers are present inside the crystal structure. In order to
determine the type of crystallization of the acetyl leucine race-
mate, physical mixtures of the racemate and of a pure enantiomer
were also analyzed by DSC and compared. The onset difference
with the previous mixtures is low (about 11) which indicates a
similar behavior for the two mixtures. The onset of acetyl-DL-
leucine is lower than the racemic mixture of acetyl-L-leucine and
acetyl-D-leucine. This result cannot happen in the case of a true
racemate. Indeed, the melting temperature of a true racemate is
always higher than the melting temperature of its eutectics. So,
the racemic conglomerate is the mode of crystallization of acetyl
leucine.
Similar results were obtained for recrystallized solid samples
obtained from aqueous solutions of acetyl leucine (Fig. 5). For a
racemic composition, the melting temperature of the recrystal-
lized sample corresponds to the eutectic melting temperature
obtained for the other enantiomerical composition. As the results
are similar to the physical mixtures ones, the formation of a
conglomerate has been demonstrated.
3.1.2. Characterization by X-ray analyzes
X-ray diffraction has been used in two main areas, for the
fingerprint characterization of crystalline materials and for the
determination of their structure. Each crystalline solid has its
unique characteristic X-ray powder pattern which may be used as
a ‘‘fingerprint’’ for its identification. The crystal structure of
acetyl-L-leucine has already been solved [23]. The crystals are
orthorhombic, and the space group is P212121. Each unit cell
contains four molecules and has the dimensions: a¼10.184 A˚,
b¼17.249 A˚ and c¼5.779 A˚. Same results are obtained from
analyzes of the crystals of acetyl-L-leucine produced industrially.
The crystallinity of the product is then well controlled.
Fig. 3. DSC analyzes as a function of the proportion of acetyl-L-leucine, for
physical mixtures of acetyl-L-leucine and acetyl-D-leucine.
Fig. 4. DSC analyzes as a function of the proportion of acetyl-L-leucine, for
physical mixtures of acetyl-DL-leucine and acetyl-L-leucine.
Fig. 5. DSC analyzes as a function of the proportion of acetyl-L-leucine, for
recrystallized samples.
Analysis also shows that the two enantiomers, acetyl-L-leucine
and acetyl-D-leucine, have the same X-ray diffractogram, so have
the same crystal structure. In that case, X-ray powder diffraction
does not enable to distinguish pure enantiomers from each other
in a physical mixture. On the contrary, a true racemate has its
own crystal structure, leading to different X-ray powder patterns
from the pure enantiomer one.
The distinction between conglomerate and true racemate can
then simply be obtained by analyzing a sample of the racemate by
X-ray diffraction. This analysis, reported in Fig. 6, shows that the
racemic form diffractogram has exactly the same peaks as the
enantiomers. It corresponds to a physical mixture of enantiomers,
thus to a conglomerate.
3.1.3. Determination of the binary diagram composed of the two
enantiomers of acetyl leucine
The DSC measurements performed in the previous section
enable to draw a part of the phase diagram of the binary D and L
acetyl leucine compounds system (see Fig. 7). This diagram
clearly shows a horizontal straight line defining the eutectic
melting temperature.
Assuming that acetyl leucine forms a conglomerate, this binary
phase diagram can also be calculated from the Schro¨der Van Laar
equation (Eq. (1)). This equation gives the liquidus curve as a
function of the enantiomerical composition:
lnðxsÞ ¼ÿDHmel
R
1
T
ÿ 1
Tmel
 
þ DCp
R
Tmel
T
ÿln Tmel
T
 
ÿ1
 
ÿlnðgsÞ ð1Þ
where
 xs is the enantiomerical molar fraction;
 DHmel is the melting enthalpy;
 DCp is the difference of specific heat capacities between the
solid and the liquid phases;
 R is the gas constant (8.314 J/K mol);
 T is the melting temperature of the mixture of enantiomers;
 Tmel is the melting temperature of pure enantiomer;
 gs is the activity coefficient of the product.
Several assumptions can be made to simplify this equation.
The first hypothesis is that the difference of specific heat capa-
cities is negligible. The second one supposes the ideal model, with
the activity coefficient equal to unity [15]. The simplified
equation (Eq. (2)) can then be rewritten as follows :
lnðxsÞ ¼ ÿDHmel
R
1
T
ÿ 1
Tmel
 
ð2Þ
On the basis of this simplified model and from the data
obtained by DSC analyzes (DHmel ¼ 31:5 kJ=mol and
Tmel¼180.5 1C), a theoretical diagram is plotted and compared
with experimental data (Fig. 7).
There are great differences between experimental data points
and the model.
By applying Eq. (2), the melting temperature of the eutectic
should be 145.8 1C instead of 158.3 1C. In order to have a model
that fits experimental data points, the melting enthalpy should be
equal to 71 kJ/mol and the melting temperature of enantiomer
should be 174 1C. Results of this model are reported in Fig. 8.
Events, like degradation [24] or chemical reactions, may occur
during the melting of a compound and modify the enthalpy
determined by DSC analyzes. Additional investigation are needed
to go further to this explanation and to determine if a simulta-
neous reaction occurs during the melting of the compound. It is
not developed in this work.
3.2. Ternary diagram of the two enantiomers of acetyl leucine and
water
3.2.1. Experimental ternary diagram
In a non-chiral solvent, opposite pure enantiomers have
always the same solubility because changes of asymmetric carbon
configuration do not modify interactions with other species in
solution. However, mixtures of enantiomers have their own
solubility. The knowledge of the solubility of a racemic mixtureFig. 6. X-ray analyzes of acetyl-D-leucine and acetyl-DL-leucine.
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Fig. 8. Experimental data and modelised melting temperature phase diagram.
in a selected solvent represents an industrial interest when
crystallization control is necessary. Furthermore, the solubility
of an API impacts its bioavailability and its therapeutic activity.
Isothermal ternary diagrams have been used by several
authors, giving the composition of each enantiomer and of the
solvent [25]. These diagrams are always symmetrical, so only one
part of them can be experimentally studied.
In the case of a conglomerate, the racemic composition has the
higher solubility and the solubility evolution from pure enantio-
mer to racemic mixture is linear. On the contrary, in the case of
true racemate, the higher solubility is obtained for the eutectic
points and a solubility decrease is observed around the racemic
composition.
Solubility measurements in water have then been carried out
for several compositions of acetyl-L-leucine and acetyl-D-leucine
in order to determine the solubility ternary diagram. The evolu-
tion of the pH of the saturated solutions during the solubility
measurements was found to be no significant and has no
influence on the measured solubility.
Mixtures of acetyl-L-leucine and acetyl-D-leucine were pre-
pared with a ratio of acetyl-L-leucine ranging from 10% to 90%.
Table 1 reports the measured solubility at a constant temperature
of 25 1C, for the considered molar ratios of L and D species. The
solubility ratio C, calculated for each mixture, is the ratio
between the solubility of this mixture and the solubility of
acetyl-L-leucine. Molar fractions of each species in solution are
also given in Table 1.
The measured solubility is low and the obtained experimental
phase diagram is given in Fig. 9.
This ternary diagram shows linear increase of solubility
toward the racemic composition. The highest solubility is
obtained for a ratio of 50% of acetyl-L-leucine, so for the racemic
composition. This diagram is characteristic of a conglomerate.
3.2.2. The Meyerhoffer double solubility rule
Conglomerates are a physical mixture of D and L crystals. In the
ideal case, no interaction between species should be observed. So
the solubility of the racemic form should be equal to the sum of
the two solubilities of each enantiomer [26] given below:
Smixture ¼ SLþSD ð3Þ
As each enantiomer has the same solubility, the solubility of
the racemic conglomerate is then doubled. This is the empirical
Meyerhoffer double solubility rule. This rule can only be applied
on conglomerates because a true racemate constitutes a single
phase with its own solubility.
However, the acetyl leucine is partially dissociated in water.
Indeed, this molecule behaves as a weak acid (pKA¼3.7) because
of the presence of a carboxylic acid group. Its solubility depends
on the pH. For pure acetyl-L-leucine, a model was proposed in a
previous work [27] in order to predict the evolution of the
solubility as a function of pH and S0, the solubility of the non-
dissociated molecule, noted ALH. S0 has been experimentally
determined to be equal to 0.045 mol/L. The solubility of a pure
enantiomer predicted by this model was noted S0 and detailed in
Eq. (4). It enabled the determination of the acidity constant KA in
the case of a saturated solution of pure enantiomer given in the
following equation:
Senantiomer ¼ S0 ¼ ½ALHþ½ALÿ ¼ S0  ð1þ10pHÿpKA Þ ð4Þ
KA ¼
½ALÿ½Hþ 
½ALH ¼
ðS0ÿS0Þ2
S0
ð5Þ
In the case of a racemic mixture for which SR is its solubility,
SR=2 is the solubility of one of the enantiomer in solution (Eq. (6))
and the concentration of hydron [Hþ] is equal to the sum of the
concentrations of the dissociated species (Eq. (7)).
Senantiomer ¼
SR
2
¼ ½ALHenantiomerþ½ALÿenantiomer
¼ S0þ½ALÿenantiomer ð6Þ
½Hþ  ¼ 2½ALÿenantiomer ð7Þ
The expression of the acidity constant for the racemate is then
given in the following equation:
KA ¼
½ALÿenantiomer½Hþ 
½ALHenantiomer
¼
2
SR
2
ÿS0
 2
S0
ð8Þ
By combining Eqs. (5) and (8), the solubility of the racemate SR
can be expressed in Eq. (9), considering the partial dissociation of
the product [7]:
SR
2
ÿS0 ¼
S0ÿS0ffiffiffi
2
p ,
so SR ¼ S0  ð2þ10pHÿpKA
ffiffiffi
2
p
Þ ð9Þ
Table 1
Experimental solubility data of mixtures of enantiomers.
Proportion
of L (%)
Solubility at
25 1C (mol/L)
Cn Molar
fraction of D
(%)
Molar
fraction of L
(%)
Molar
fraction
of S (%)
0 0.0499 1.05 0.090 0.000 99.910
10 0.0546 1.15 0.088 0.010 99.902
20 0.0617 1.30 0.089 0.022 99.889
30 0.0700 1.47 0.088 0.038 99.874
40 0.0785 1.65 0.085 0.056 99.859
50 0.0920 1.93 0.083 0.083 99.835
60 0.0803 1.68 0.058 0.087 99.856
70 0.0686 1.44 0.037 0.086 99.877
80 0.0633 1.33 0.023 0.091 99.886
90 0.0564 1.18 0.010 0.091 99.899
100 0.0477 1.00 0.000 0.086 99.914
Fig. 9. Ternary phase diagram of solubility of acetyl leucine at a constant
temperature of 25 1C.
As the pH in saturated solutions is equal to 2.6, the theoretical
solubility ratio C calculated by Eq. (10) is equal to 1.96:
Sracemic
Senantiomer
¼ 2þ10
pHÿpKA ffiffiffi2p
1þ10pHÿpKA
ð10Þ
Experimentally, the racemate solubility ratio is equal to 1.93
(Table 1). The model which considers the partial dissociation of
the product gives better results than the empirical Meyerhoffer
rule. The slight difference with the experimental results could be
attributed to the non-ideality of the system and to the interaction
between the enantiomers.
The next step is then to develop a model which predicts the
solubility, not only for the racemic composition, but as a function
of the enantiomerical composition.
3.2.3. Solubility model for conglomerates
The proportion of acetyl-L-leucine is noted x. When acetyl-D-
leucine is the main compound (x r 50%), the solubility of acetyl-
D-leucine SD is equal to the solubility of the pure enantiomer S
0. By
molar balance and using Eq. (3), SL is equal to ðx=ð1ÿxÞÞS0 The case
is symmetrical when acetyl-L-leucine is the main compound. This
simple model gives two cases summarized in the following
equation:
For xr50%,SD ¼ S0 and SL ¼
x
1ÿx S
0
,
so Smixture ¼ S0 1þ
x
1ÿx
 
¼ S
0
1ÿx ð11Þ
For xZ50%,SL ¼ S0 and SD ¼
1ÿx
x
S0,
so Smixture ¼ S0 1þ
1ÿx
x
 
¼ S
0
x
ð12Þ
To check the validity of the model, the calculated solubilities
were compared to the experimental ones, in the case of acetyl-L-
leucine (the example is symmetrical with the enantiomerical
counterpart). Fig. 10 shows the evolution of the experimental
partial solubility as a function of the partial solubility predicted
by the model. The evolution clearly shows a straight line which
confirms that the model is correct. However, the slope is not
exactly equal to unity. This could be due to slight interactions
between enantiomers that decrease the solubility of the mixture.
4. Conclusion
This paper shows that acetyl-DL-leucine crystallizes as a con-
glomerate. A model has then been developed to describe the
solubility profile as a function of pH and enantiomerical
compositions.
Melting points measured by thermal analyzes showed differ-
ences with the values predicted by the Schro¨der Van Laar equation.
That could be explained by the existence of a concomitant phenom-
enon during the melting. Further work will be done to explain this.
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Fig. 10. Comparison of experimental and calculated solubilities.
